I agree that this site is using cookies. You can find further informations here.
X
Casslén, B.
34  results:
Search for persons X
?
1

G protein-coupled estrogen receptor 1 (GPER, GPR 30) in nor..:

Kolkova, Z. ; Noskova, V. ; Ehinger, A...
Molecular Human Reproduction.  16 (2010)  10 - p. 743-751 , 2010
Link: https://doi.org/10.1093/..
 
?
2

O157 The membrane bound G‐protein coupled receptor, GPR30, ..:

Casslen, B. ; Henic, E.
International Journal of Gynecology & Obstetrics.  107 (2009)  S2 - p. , 2009
Link: https://doi.org/10.1016/..
 
?
3

P1020 Cleaved forms of the upa receptor in plasma have diag..:

Henic, E. ; Borgfeldt, C. ; Christensen, I...
International Journal of Gynecology & Obstetrics.  107 (2009)  S2 - p. , 2009
Link: https://doi.org/10.1016/..
 
?
4

Monoamine transporters in human endometrium and decidua:

Hansson, S. R. ; Bottalico, B. ; Noskova, V..
Human Reproduction Update.  15 (2008)  2 - p. 249-260 , 2008
Link: https://doi.org/10.1093/..
 
?
5

Endometrial expression of the estrogen-sensitive genes MMP-..:

Pilka, R. ; Oborna, I. ; Lichnovsky, V....
Human Reproduction.  21 (2006)  12 - p. 3146-3156 , 2006
Link: https://doi.org/10.1093/..
 
?
6

ID: 281 An in vitro model for tumor cell - stromal cell cro..:

Noskova, V. ; Casslén, B.
Journal of Thrombosis and Haemostasis.  4 (2006)  s1 - p. 77-77 , 2006
Link: https://doi.org/10.1111/..
 
?
7

ID: 280 Estradiol inhibits EGF-induced mobilization of uPAR..:

Casslén, B. ; Henic, E. ; Noskova, V...
Journal of Thrombosis and Haemostasis.  4 (2006)  s1 - p. 76-76 , 2006
Link: https://doi.org/10.1111/..
 
?
8

Matrix metalloproteinase-26 (Matrilysin-2) expression is hi..:

Pilka, R. ; Norata, G.D. ; Domanski, H....
Gynecologic Oncology.  94 (2004)  3 - p. 661-670 , 2004
Link: https://doi.org/10.1016/..
 
?
9

Norepinephrine Transporter (NET), Serotonin Transporter (SE..:

Bottalico, B ; Larsson, I ; Brodszki, J...
Placenta.  25 (2004)  6 - p. 518-529 , 2004
Link: https://doi.org/10.1016/..
 
?
10

Diagnosis of endometrial cancer in patients with postmenopa..:

NIKLASSON, O ; SKUDE, G ; MARSAL, K.
Gynecologic Oncology.  93 (2004)  2 - p. 385-389 , 2004
Link: https://doi.org/10.1016/..
 
?
11

Urokinase plasminogen activator and its inhibitor, PAI-1, i..:

Fredstorp-Lidebring, M ; Bendahl, P.-O ; Brünner, N...
European Journal of Cancer.  37 (2001)  18 - p. 2339-2348 , 2001
Link: https://doi.org/10.1016/..
 
?
12

Degradation of urokinase plasminogen activator (UPA) in end..:

Casslen, B. ; Gustavsson, B. ; Angelin, B..
Molecular Human Reproduction.  4 (1998)  6 - p. 585-593 , 1998
Link: https://doi.org/10.1093/..
 
?
13

113 Soluble receptors for u-PA in blood and peritoneal-asci..:

Wahlberg, K. ; Høyer-Hansen, G. ; Casslén, B.
Fibrinolysis and Proteolysis.  11 (1997)  - p. 32 , 1997
Link: https://doi.org/10.1016/..
 
?
14

110 Content and localization of protein and mRNA for plasmi..:

Nordengren, J. ; Casslén, B. ; Gustavsson, B.
Fibrinolysis and Proteolysis.  11 (1997)  - p. 31 , 1997
Link: https://doi.org/10.1016/..
 
?
15

Plasminogen activator inhibitor 2 in menstrual endometrium ..:

Nordengren, J. ; Casslén, B. ; Lecander, I.
Fibrinolysis.  10 (1996)  5-6 - p. 295-302 , 1996
Link: https://doi.org/10.1016/..
 
1-15